🇺🇸 FDA
Patent

US 10624878

Tetrahydro-1H-pyrido [3,4-b]indole anti-estrogenic drugs

granted A61KA61K31/437A61K31/4545

Quick answer

US patent 10624878 (Tetrahydro-1H-pyrido [3,4-b]indole anti-estrogenic drugs) held by Olema Pharmaceuticals, Inc. expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Olema Pharmaceuticals, Inc.
Grant date
Tue Apr 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K31/437, A61K31/4545, A61K31/475, A61K31/506